Pharming (PHAR) Operating Leases (2018 - 2025)
Pharming's (PHAR) quarterly Operating Leases came in at $14.4 million in Q4 2025, down 52.03% YoY from $29.9 million in Q4 2024, and down 52.03% on a QoQ basis from $29.9 million in Q4 2024.
Pharming (PHAR) Operating Leases (2018 - 2025) Analysis & Trends
Pharming (PHAR) has 8 years of Operating Leases data on file, last reported at $14.4 million in Q4 2025.
- Quarterly Operating Leases fell 52.03% year-over-year to $14.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.4 million (down 52.03% YoY) and the FY2025 annual result came in at $14.4 million, down 52.03% from the prior year.
- Operating Leases slipped to $14.4 million in Q4 2025, from $29.9 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $33.3 million in Q4 2022 to a low of $14.4 million in Q4 2025.
- A 5-year average of $26.3 million and a median of $29.9 million in 2024 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2021 — Operating Leases jumped 110.94% — and 2025, when it sank 52.03%.
- Tracing PHAR's Operating Leases over 5 years: stood at $20.9 million in 2021, then jumped by 59.56% to $33.3 million in 2022, then slipped by 0.56% to $33.1 million in 2023, then decreased by 9.69% to $29.9 million in 2024, then slumped by 52.03% to $14.4 million in 2025.
- The last three Operating Leases figures came in at $14.4 million (Q4 2025), $29.9 million (Q4 2024), and $33.1 million (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Pharming | 824.47 Mn | 666.19 Mn | 141.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.35 Mn |
| Dec 31, 2024 | 29.91 Mn |
| Dec 31, 2023 | 33.12 Mn |
| Dec 31, 2022 | 33.31 Mn |
| Dec 31, 2021 | 20.88 Mn |
| Dec 31, 2020 | 9.90 Mn |
| Dec 31, 2019 | 4.83 Mn |
| Dec 31, 2018 | 5.96 Mn |